hypersensitivity reaction to its use.[edit] Adverse reactionsAdverse reactions include reproductive system and breast disorders, breast tenderness, gynaecomastia, hot flushes, gastrointestinal disorders, bickalutalibt casodex nausea, hepatic changes (elevated bickalutalibt casodex of transaminases, jaundice), asthenia and pruritus.[edit] External linksCasodex.

modulator: Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, ToremifeneAromatase inhibitor: Aminogluthetimide, Anastrozole, bickalutalibt casodex Formestane, Letrozole, VorozoleGonadotropins:(FSHR/LHCGR) ovulation stim.: Clomifene, UrofollitropinAntigonadotropins: Danazol, GestrinoneGnRH:(receptor) bickalutalibt casodex Buserelin, Goserelin, Histrelin, Leuprorelin, Nafarelin, Triptorelinantagonist: bickalutalibt casodex Cetrorelix, Ganirelix BicalutamideFrom Wikipedia, the free encyclopedia(Redirected from Casodex)Jump to: navigation, searchBicalutamideSystematic (IUPAC) nameN-[4-cyano-3-(trifluoromethyl)phenyl]- 3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methyl- propanamideIdentifiersCAS number 90357-06-5ATC code L02BB03PubChem 56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374 g/molPharmacokinetic dataBioavailability well absorbedProtein binding 96%Metabolism hepaticHalf life 5.8 daysExcretion bickalutalibt casodex ?Therapeutic considerationsPregnancy cat. X(US)Legal status ? Prescription onlyRoutes OralBicalutamide.

number 90357-06-5ATC code L02BB03PubChem 56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374.